Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 10.5 CNY -2.33%
Market Cap: 4.6B CNY
Have any thoughts about
Hunan Fangsheng Pharmaceutical Co Ltd?
Write Note

Hunan Fangsheng Pharmaceutical Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hunan Fangsheng Pharmaceutical Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Cost of Revenue
-ÂĄ541.1m
CAGR 3-Years
1%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cost of Revenue
-ÂĄ1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cost of Revenue
-ÂĄ6.1B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cost of Revenue
-ÂĄ3.9B
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cost of Revenue
-ÂĄ28.8B
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cost of Revenue
-ÂĄ242.3m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hunan Fangsheng Pharmaceutical Co Ltd
Glance View

Market Cap
4.6B CNY
Industry
Pharmaceuticals

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.

Intrinsic Value
15 CNY
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Hunan Fangsheng Pharmaceutical Co Ltd's Cost of Revenue?
Cost of Revenue
-541.1m CNY

Based on the financial report for Sep 30, 2024, Hunan Fangsheng Pharmaceutical Co Ltd's Cost of Revenue amounts to -541.1m CNY.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%

Over the last year, the Cost of Revenue growth was 1%. The average annual Cost of Revenue growth rates for Hunan Fangsheng Pharmaceutical Co Ltd have been 1% over the past three years , -12% over the past five years , and -9% over the past ten years .

Back to Top